Preliminary experiments reveal conolidine may well inhibit specific ion channels, minimizing neuronal excitability and limiting discomfort signals. This system is especially suitable in neuropathic suffering, wherever irregular signaling leads to persistent distress. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR) pathways